North China Pharmaceutical (SHA:600812) received 94.9 million yuan in compensation after the government acquired its plot of land in Shijiazhuang City, Hebei, China, according to a Saturday filing with the Shanghai bourse.
The company will use the funds to reduce relocation and work stoppage losses for the same amount, the filing said.